Sandeep Nathan, MD, is a highly skilled cardiologist who specializes in interventional cardiovascular procedures. Dr. Nathan performs a wide range of coronary and peripheral vascular procedures for the diagnosis and treatment of cardiovascular disease, including balloon angioplasty, stenting, atherectomy, thrombectomy, cryoplasty and intravascular ultrasound imaging.
He is one of few interventional cardiologists who routinely perform transradial angiography and intervention, a less invasive alternative to traditional approaches. Transradial angiography uses an artery in the wrist, instead of the leg, as the entryway for diagnostic imaging and therapeutic procedures, such as angioplasty and stenting. This technique offers fewer risks and greater advantages, including increased patient comfort and immediate mobility following the procedure. Additionally, Dr. Nathan is a general cardiologist who treats patients with coronary artery disease (CAD), peripheral arterial disease (PAD) and risk factors for heart disease.
His research interests include platelet biology, interventional device therapies, intravascular imaging, and the use of antiplatelet and antithrombotic therapies (blood thinners) in the management of acute coronary syndromes and heart attacks. Dr. Nathan holds a master's degree in clinical research. He currently serves as a principal investigator or co-investigator on several clinical trials evaluating: new antiplatelet therapies in patients with acute coronary syndromes; novel stents for the treatment of coronary artery disease; and clinical outcomes in patients who have had percutaneous coronary interventions (angioplasty/stent) and heart attacks.
Shortened dual antiplatelet therapy duration after percutaneous patent foramen ovale and atrial septal defect closure.
Shortened dual antiplatelet therapy duration after percutaneous patent foramen ovale and atrial septal defect closure. J Invasive Cardiol. 2025 Dec; 37(12).
PMID: 40815602
Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis.
Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis. Eur J Heart Fail. 2025 Nov; 27(11):2244-2258.
PMID: 40956069
Comparison of Heart Failure Cardiogenic Shock Patients with Axillary and Femoral Intra-aortic Balloon Pump: Cardiogenic Shock Working Group report.
Comparison of Heart Failure Cardiogenic Shock Patients with Axillary and Femoral Intra-aortic Balloon Pump: Cardiogenic Shock Working Group report. J Card Fail. 2026 Feb; 32(2):394-405.
PMID: 40846302
Expanding the Role of Drug-Coated Balloons in Contemporary Percutaneous Coronary Intervention: Start of the Next Revolution or Just One More Weapon in a Growing Arsenal?
Expanding the Role of Drug-Coated Balloons in Contemporary Percutaneous Coronary Intervention: Start of the Next Revolution or Just One More Weapon in a Growing Arsenal? J Am Heart Assoc. 2025 Jun 03; 14(11):e042448.
PMID: 40439167
Robotic Totally Endoscopic Reverse Hybrid Coronary Revascularization: Early and Midterm Outcomes.
Robotic Totally Endoscopic Reverse Hybrid Coronary Revascularization: Early and Midterm Outcomes. Innovations (Phila). 2025 May-Jun; 20(3):276-282.
PMID: 40359074
Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock.
Outcomes With Femoral IABP in Heart Failure and Acute Myocardial Infarction-Related Cardiogenic Shock. J Card Fail. 2025 May 09.
PMID: 40348328
Worsening Renal Function Is Common and Is Associated With Higher Mortality Rates in Cardiogenic Shock: A Cardiogenic Shock Working Group Report.
Worsening Renal Function Is Common and Is Associated With Higher Mortality Rates in Cardiogenic Shock: A Cardiogenic Shock Working Group Report. J Card Fail. 2025 Apr 01.
PMID: 40180238
Alternative Access for Transcatheter Aortic Valve Replacement: An Ode to the Road Less Traveled.
Alternative Access for Transcatheter Aortic Valve Replacement: An Ode to the Road Less Traveled. J Soc Cardiovasc Angiogr Interv. 2025 Mar; 4(3Part A):102581.
PMID: 40231058
Supersaturated Oxygen Therapy as a Treatment for No Reflow.
Supersaturated Oxygen Therapy as a Treatment for No Reflow. JACC Case Rep. 2025 Feb 05; 30(3):103102.
PMID: 39963230
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience.
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience. J Neurointerv Surg. 2024 Nov 22; 16(12):1244-1249.
PMID: 38171608